| 1 | Breast Neoplasms, Male | 47.5% |
| 2 | Carcinoma, Lobular | 34.4% |
| 3 | Skin Neoplasms | 28.2% |
| 4 | Gynecomastia | 23.1% |
| 5 | Breast Cyst | 22.7% |
| 6 | Abdominal Neoplasms | 20.2% |
| 7 | Head and Neck Neoplasms | 20.2% |
| 8 | Soft Tissue Neoplasms | 20.2% |
| 9 | Thoracic Neoplasms | 20.2% |
| 10 | Sebaceous Gland Neoplasms | 19.9% |
| 11 | Pyoderma Gangrenosum | 17.9% |
| 12 | Lactation Disorder | 17.4% |
| 13 | Mastitis | 17.4% |
| 14 | Lupus Erythematosus, Cutaneous | 17.1% |
| 15 | Panniculitis | 17.1% |
| 16 | Systemic Scleroderma | 17.1% |
| 17 | Morphea | 17.1% |
| 18 | Dermatitis | 16.9% |
| 19 | Exanthema | 16.9% |
| 20 | Facial Dermatoses | 16.9% |
| 21 | Hair Diseases | 16.9% |
| 22 | Hand Dermatoses | 16.9% |
| 23 | keratoacanthoma | 16.9% |
| 24 | Keratosis | 16.9% |
| 25 | Nail Diseases | 16.9% |
| 26 | Photosensitivity Disorders | 16.9% |
| 27 | Prurigo | 16.9% |
| 28 | Pyoderma | 16.9% |
| 29 | Rosacea | 16.9% |
| 30 | Sebaceous Gland Diseases | 16.9% |
| 31 | Skin Diseases, Vesiculobullous | 16.9% |
| 32 | Skin Ulcer | 16.9% |
| 33 | Sweat Gland Diseases | 16.9% |
| 34 | Skin Diseases, Papulosquamous | 16.9% |
| 35 | Skin Diseases, Vascular | 16.9% |
| 36 | Acneiform Eruptions | 16.9% |
| 37 | Ocular Rosacea | 16.9% |
| 38 | Subcorneal pustular dermatosis | 16.9% |
| 39 | Erythematotelangiectatic Rosacea | 16.9% |
| 40 | Papulopustular Rosacea | 16.9% |
| 41 | Chronic Actinic Dermatitis | 16.9% |
| 42 | Digestive System Neoplasms | 15.9% |
| 43 | Endocrine Gland Neoplasms | 15.9% |
| 44 | Eye Neoplasms | 15.9% |
| 45 | Nervous System Neoplasms | 15.9% |
| 46 | Bone neoplasms | 15.4% |
| 47 | Hematologic Neoplasms | 15.4% |
| 48 | Splenic Neoplasms | 15.1% |
| 49 | Acne Vulgaris | 14.9% |
| 50 | Contact Dermatitis | 14.9% |
| 51 | Eczema | 14.9% |
| 52 | Erythema Multiforme | 14.9% |
| 53 | Intertrigo | 14.9% |
| 54 | Neurodermatitis | 14.9% |
| 55 | Rhinophyma | 14.9% |
| 56 | Perioral Dermatitis | 14.9% |
| 57 | Acne | 14.9% |
| 58 | Xeroderma Pigmentosum | 14% |
| 59 | Parathyroid Neoplasms | 13.6% |
| 60 | Peritoneal Neoplasms | 13.6% |
| 61 | Thyroid Neoplasm | 13.6% |
| 62 | Thyroid carcinoma | 13.6% |
| 63 | Foot Diseases | 13.3% |
| 64 | Retroperitoneal Neoplasms | 13.2% |
| 65 | Skin Abnormalities | 12.8% |
| 66 | Skin Diseases, Infectious | 12.8% |
| 67 | Pigmentation Disorders | 12.8% |
| 68 | Dermatitis, Atopic | 12.8% |
| 69 | Epidermolysis Bullosa | 12.8% |
| 70 | Actinic keratosis | 12.6% |
| 71 | Lipomatosis | 12.6% |
| 72 | Pruritus | 12.6% |
| 73 | Erythema | 12.6% |
| 74 | Necrolytic Migratory Erythema | 12.6% |
| 75 | Cutaneous Fistula | 12.6% |
| 76 | Nephrogenic Fibrosing Dermopathy | 12.6% |
| 77 | Nephrogenic Systemic Fibrosis | 12.6% |
| 78 | Foot Ulcer | 12.3% |
| 79 | Acanthoma | 12.3% |
| 80 | Paraneoplastic Encephalomyelitis | 12.2% |
| 81 | Dermatitis Herpetiformis | 12.1% |
| 82 | Mammary Neoplasms, Experimental | 12% |
| 83 | Mastocytosis | 12% |
| 84 | Acrodermatitis | 11.9% |
| 85 | Porokeratosis | 11.9% |
| 86 | Gianotti-Crosti Syndrome | 11.9% |
| 87 | Keratoderma, Palmoplantar | 11.9% |
| 88 | Tracheal Neoplasms | 11.8% |
| 89 | Hamartoma | 11.8% |
| 90 | Neoplasms, Hormone-Dependent | 11.8% |
| 91 | Neoplasms, Multiple Primary | 11.8% |
| 92 | Paraneoplastic Syndromes | 11.8% |
| 93 | Precancerous Conditions | 11.8% |
| 94 | Neoplasms, Second Primary | 11.8% |
| 95 | Multiple Endocrine Neoplasia | 11.7% |
| 96 | Pancreatic Neoplasm | 11.7% |
| 97 | Dermatitis, Phototoxic | 11.7% |
| 98 | Pityriasis Lichenoides et Varioliformis Acuta | 11.7% |
| 99 | Pityriasis Lichenoides | 11.7% |
| 100 | Phototoxicity | 11.7% |
| 101 | Galactorrhea | 11.4% |
| 102 | Urticaria Pigmentosa | 11.2% |
| 103 | Dermatomyositis | 11.1% |
| 104 | Necrobiosis Lipoidica Diabeticorum | 11% |
| 105 | Panniculitis, Lupus Erythematosus | 10.9% |
| 106 | Connective Tissue Diseases | 10.6% |
| 107 | Mouth Neoplasms | 10.1% |
| 108 | Central Nervous System Neoplasms | 10.1% |
| 109 | Vascular Neoplasms | 10.1% |
| 110 | Thymus Neoplasms | 10.1% |
| 111 | Xeroderma | 10.1% |
| 112 | Genital Neoplasms, Female | 9.9% |
| 113 | Lupus Erythematosus, Discoid | 9.9% |
| 114 | Scleroderma, Limited | 9.9% |
| 115 | Esophageal Neoplasms | 9.9% |
| 116 | Anhidrosis | 9.9% |
| 117 | Cholesteatoma | 9.9% |
| 118 | Pressure Ulcer | 9.9% |
| 119 | Folliculitis | 9.9% |
| 120 | Foot Dermatoses | 9.9% |
| 121 | Hypertrichosis | 9.9% |
| 122 | Hypohidrosis | 9.9% |
| 123 | Hypotrichosis | 9.9% |
| 124 | Leg Ulcer | 9.9% |
| 125 | Miliaria | 9.9% |
| 126 | Parakeratosis | 9.9% |
| 127 | Parapsoriasis | 9.9% |
| 128 | Pityriasis | 9.9% |
| 129 | Psoriasis | 9.9% |
| 130 | Sweet Syndrome | 9.9% |
| 131 | Hidradenitis | 9.9% |
| 132 | Onycholysis | 9.9% |
| 133 | Miliaria Rubra | 9.9% |
| 134 | Hyperpigmentation | 9.9% |
| 135 | Lichenoid Eruptions | 9.9% |
| 136 | Chloracne | 9.9% |
| 137 | Thyroid Nodule | 9.8% |
| 138 | Dermatitis, Irritant | 9.8% |
| 139 | Acne Conglobata | 9.8% |
| 140 | Dermatitis, Photoallergic | 9.7% |
| 141 | Cutis Laxa | 9.4% |
| 142 | Mastocytoma | 9.4% |
| 143 | Erythema Induratum | 9.2% |
| 144 | Cyst | 8.8% |
| 145 | Neoplastic Processes | 8.8% |
| 146 | Neoplastic Syndromes, Hereditary | 8.8% |
| 147 | Pregnancy Complications, Neoplastic | 8.8% |
| 148 | Testicular Neoplasms | 8.7% |
| 149 | Neoplasms, Experimental | 8.7% |
| 150 | Thymoma | 8.6% |
| 151 | Ectodermal Dysplasia | 8.5% |
| 152 | Aplasia Cutis Congenita | 8.5% |
| 153 | Pseudoxanthoma Elasticum | 8.5% |
| 154 | Meningioma | 8.4% |
| 155 | Erythema Infectiosum | 8.3% |
| 156 | Exanthema Subitum | 8.3% |
| 157 | Carcinoma, Pancreatic Ductal | 8.2% |
| 158 | Adrenal Gland Neoplasms | 8.2% |
| 159 | Gastrointestinal Neoplasms | 8.2% |
| 160 | Genital Neoplasms, Male | 8.2% |
| 161 | Liver neoplasms | 8.2% |
| 162 | Dermatitis, Occupational | 8.2% |
| 163 | Uveal Neoplasms | 8.2% |
| 164 | Erythema Nodosum | 8.2% |
| 165 | Urologic Neoplasms | 8.1% |
| 166 | Multiple Endocrine Neoplasia Type 1 | 8% |
| 167 | Spinal Neoplasms | 7.9% |
| 168 | Bone Marrow Neoplasms | 7.9% |
| 169 | Dermatitis, Allergic Contact | 7.8% |
| 170 | Papillon-Lefevre Disease | 7.8% |
| 171 | Carcinoma 256, Walker | 7.6% |
| 172 | Acantholysis | 7.6% |
| 173 | Pemphigoid, Benign Mucous Membrane | 7.6% |
| 174 | Pemphigus | 7.6% |
| 175 | Piedra | 7.6% |
| 176 | Sunburn | 7.6% |
| 177 | Myxoid cyst | 7.6% |
| 178 | Carcinoma, Ehrlich Tumor | 7.5% |
| 179 | Dermoid Cyst | 7.5% |
| 180 | Carcinoma, Lewis Lung | 7.5% |
| 181 | Argyria | 7.4% |
| 182 | Hirsutism | 7.4% |
| 183 | Urticaria | 7.4% |
| 184 | Adiposis Dolorosa | 7.4% |
| 185 | Meningeal Neoplasms | 7.4% |
| 186 | Pruritus Vulvae | 7.4% |
| 187 | Pruritus Ani | 7.3% |
| 188 | Toxic Epidermal Necrolysis | 7.3% |
| 189 | Stevens-Johnson Syndrome | 7.3% |
| 190 | Tinea Capitis | 7.3% |
| 191 | Onychomycosis | 7.3% |
| 192 | Diaper Rash | 7.3% |
| 193 | Granuloma Annulare | 7.2% |
| 194 | Leukoplakia, Oral | 7.1% |
| 195 | Liver Neoplasms, Experimental | 7.1% |
| 196 | Paraneoplastic Cerebellar Degeneration | 7.1% |
| 197 | insulinoma | 7% |
| 198 | Ecthyma | 7% |
| 199 | Vipoma | 7% |
| 200 | Neoplasms, Radiation-Induced | 6.9% |
| 201 | Gastrinoma | 6.9% |
| 202 | Glucagonoma | 6.9% |
| 203 | Acoustic Neuroma | 6.9% |
| 204 | Nose Neoplasms | 6.8% |
| 205 | Erythroplasia | 6.7% |
| 206 | Follicular cyst | 6.7% |
| 207 | leukemia | 6.7% |
| 208 | Mucocele | 6.7% |
| 209 | Neoplasms, Germ Cell and Embryonal | 6.7% |
| 210 | Neoplasms, Glandular and Epithelial | 6.7% |
| 211 | Pilonidal Cyst | 6.7% |
| 212 | Thyroglossal Cyst | 6.7% |
| 213 | Synovial Cyst | 6.7% |
| 214 | Germ Cell Cancer | 6.7% |
| 215 | Aberrant Crypt Foci | 6.7% |
| 216 | Palatal Neoplasms | 6.7% |
| 217 | Trophoblastic Neoplasms | 6.7% |
| 218 | Leukemia, Experimental | 6.7% |
| 219 | Neuroectodermal Tumors | 6.6% |
| 220 | Hepatocellular Adenoma | 6.6% |
| 221 | Neoplasms, Neuroepithelial | 6.5% |
| 222 | Gliomatosis cerebri | 6.5% |
| 223 | Lichen Planus | 6.5% |
| 224 | Melanosis | 6.5% |
| 225 | Chloasma | 6.5% |
| 226 | Pityriasis Rosea | 6.5% |
| 227 | Pityriasis Rubra Pilaris | 6.5% |
| 228 | Vitiligo | 6.5% |
| 229 | Lichen Nitidus | 6.5% |
| 230 | Melanoma, Experimental | 6.3% |
| 231 | Ichthyosis, X-Linked | 6.2% |
| 232 | Sjogren-Larsson Syndrome | 6.2% |
| 233 | Behcet Syndrome | 6.2% |
| 234 | Retinoblastoma | 6.2% |
| 235 | Ear Neoplasms | 6.1% |
| 236 | Eyelid Neoplasms | 6.1% |
| 237 | Lung Neoplasms | 6.1% |
| 238 | Pleural Neoplasms | 6.1% |
| 239 | Limbic Encephalitis | 6.1% |
| 240 | Meningeal Carcinomatosis | 6.1% |
| 241 | Dermatomycoses | 6% |
| 242 | Mucocutaneous Lymph Node Syndrome | 6% |
| 243 | Skin Diseases, Bacterial | 6% |
| 244 | Hyperkeratosis, Epidermolytic | 6% |
| 245 | Pituitary Adenoma | 6% |
| 246 | Pituitary Neoplasms | 6% |
| 247 | Drug Eruptions | 6% |
| 248 | Lipodystrophy | 6% |
| 249 | Sarcoma, Experimental | 6% |
| 250 | Livedo Reticularis | 6% |
| 251 | Malignant Atrophic Papulosis | 6% |
| 252 | Leydig Cell Tumor | 6% |
| 253 | Brain Neoplasms | 5.9% |
| 254 | Salivary Gland Neoplasms | 5.9% |
| 255 | Spinal Cord Neoplasms | 5.9% |
| 256 | Tongue Neoplasms | 5.9% |
| 257 | Polyarteritis Nodosa | 5.9% |
| 258 | Takayasu Arteritis | 5.9% |
| 259 | melanoma | 5.8% |
| 260 | Uterine Neoplasms | 5.8% |
| 261 | Vaginal Neoplasms | 5.8% |
| 262 | Vulvar Neoplasms | 5.8% |
| 263 | Uterine Cancer | 5.8% |
| 264 | Fallopian Tube Neoplasms | 5.8% |
| 265 | Carcinosarcoma | 5.7% |
| 266 | Hemangiosarcoma | 5.7% |
| 267 | Leukemia L1210 | 5.7% |
| 268 | Leukemia P388 | 5.7% |
| 269 | lymphangiosarcoma | 5.7% |
| 270 | Nephroblastoma | 5.7% |
| 271 | Optic Nerve Glioma | 5.7% |
| 272 | ovarian neoplasm | 5.7% |
| 273 | Collagen Diseases | 5.6% |
| 274 | Leukemia, Radiation-Induced | 5.6% |
| 275 | Mixed Connective Tissue Disease | 5.6% |
| 276 | Mucinoses | 5.6% |
| 277 | Hidradenitis Suppurativa | 5.6% |
| 278 | Prolactinoma | 5.6% |
| 279 | Growth Hormone-Secreting Pituitary Adenoma | 5.6% |
| 280 | Medulloblastoma | 5.6% |
| 281 | Tuberous Sclerosis | 5.5% |
| 282 | Albinism | 5.5% |
| 283 | Lambert-Eaton Myasthenic Syndrome | 5.4% |
| 284 | Erythema Chronicum Migrans | 5.4% |
| 285 | Peutz-Jeghers Syndrome | 5.4% |
| 286 | Sarcoma 180 | 5.3% |
| 287 | Adenoma, Acidophil | 5.2% |
| 288 | Ganglioneuroma | 5.2% |
| 289 | Glioma | 5.2% |
| 290 | Malignant Glioma | 5.2% |
| 291 | Choriocarcinoma | 5.1% |
| 292 | Leukoplakia | 5.1% |
| 293 | Lymphocele | 5.1% |
| 294 | Pancreatic Cyst | 5.1% |
| 295 | Pharyngeal Neoplasms | 5.1% |
| 296 | Nail-Patella Syndrome | 5.1% |
| 297 | Barrett Esophagus | 5% |
| 298 | Histiocytic Disorders, Malignant | 5% |
| 299 | Mediastinal Cyst | 5% |
| 300 | Neoplasm Invasiveness | 5% |
| 301 | Neoplasm Metastasis | 5% |
| 302 | Neoplasm Recurrence, Local | 5% |
| 303 | Parovarian Cyst | 5% |
| 304 | Pericardial Cyst | 5% |
| 305 | Thymic Cyst | 5% |
| 306 | Carcinogenesis | 5% |
| 307 | Metastasis | 5% |
| 308 | Porphyrias, Hepatic | 5% |
| 309 | Alopecia | 5% |
| 310 | Sweating, Gustatory | 5% |
| 311 | Androgenetic Alopecia | 5% |
| 312 | Auriculotemporal Syndrome | 5% |
| 313 | Central Nervous System Cysts | 5% |
| 314 | Bronchial Neoplasms | 5% |
| 315 | Bile Duct Neoplasms | 4.9% |
| 316 | gallbladder neoplasm | 4.9% |
| 317 | Intestinal Neoplasms | 4.9% |
| 318 | Penile Neoplasms | 4.9% |
| 319 | Prostatic Neoplasms | 4.9% |
| 320 | Stomach Neoplasms | 4.9% |
| 321 | Lice Infestations | 4.9% |
| 322 | Varicose Ulcer | 4.9% |
| 323 | Multiple Pulmonary Nodules | 4.9% |
| 324 | Basal cell carcinoma | 4.9% |
| 325 | Carcinoma, Papillary | 4.9% |
| 326 | Squamous cell carcinoma | 4.9% |
| 327 | Chondrosarcoma | 4.9% |
| 328 | Craniopharyngioma | 4.9% |
| 329 | Cystadenoma | 4.9% |
| 330 | leiomyosarcoma | 4.9% |
| 331 | liposarcoma | 4.9% |
| 332 | Mesothelioma | 4.9% |
| 333 | synovial sarcoma | 4.9% |
| 334 | Neuroectodermal Tumor, Melanotic | 4.9% |
| 335 | Angiomyolipoma | 4.9% |
| 336 | Clear Cell Sarcoma of Soft Tissue | 4.9% |
| 337 | Alveolar Soft Part Sarcoma | 4.9% |
| 338 | Neuroendocrine Tumors | 4.9% |
| 339 | Sarcoma, Myeloid | 4.9% |
| 340 | Carcinoma, Basal Cell | 4.9% |
| 341 | Acanthosis Nigricans | 4.9% |
| 342 | Alopecia Areata | 4.9% |
| 343 | Lentigo | 4.9% |
| 344 | Polycythemia Vera | 4.9% |
| 345 | Supratentorial Neoplasms | 4.9% |
| 346 | granulosa cell tumor | 4.9% |
| 347 | Carcinoma, Ovarian Epithelial | 4.9% |
| 348 | Tinea Pedis | 4.8% |
| 349 | Carcinoid Tumor | 4.8% |
| 350 | Endometrial Neoplasms | 4.8% |
| 351 | Neurilemmoma | 4.8% |
| 352 | Hutchinson's Melanotic Freckle | 4.8% |
| 353 | Melanoma, Amelanotic | 4.8% |
| 354 | Dupuytren Contracture | 4.8% |
| 355 | Opsoclonus-Myoclonus Syndrome | 4.8% |
| 356 | Mesoblastic Nephroma | 4.6% |
| 357 | Lymphomatoid Granulomatosis | 4.6% |
| 358 | Adrenocortical carcinoma | 4.6% |
| 359 | Leukemia, Plasma Cell | 4.6% |
| 360 | Adenomatous Polyposis Coli | 4.5% |
| 361 | Astrocytoma | 4.5% |
| 362 | Ependymoma | 4.5% |
| 363 | oligodendroglioma | 4.5% |
| 364 | Ganglioglioma | 4.5% |
| 365 | gliosarcoma | 4.5% |
| 366 | Anaplastic astrocytoma | 4.5% |
| 367 | Anaplastic Oligodendroglioma | 4.5% |
| 368 | Cystadenocarcinoma | 4.5% |
| 369 | Fibrosarcoma | 4.5% |
| 370 | Osteosarcoma | 4.5% |
| 371 | Mucoepidermoid Carcinoma | 4.5% |
| 372 | Cartilage Diseases | 4.4% |
| 373 | Rheumatism | 4.4% |
| 374 | Chondromalacia | 4.4% |
| 375 | Laryngeal neoplasm | 4.4% |
| 376 | Adenoma | 4.4% |
| 377 | Ameloblastoma | 4.4% |
| 378 | Angiokeratoma | 4.4% |
| 379 | Carcinoma | 4.4% |
| 380 | Chordoma | 4.4% |
| 381 | Hemangioma | 4.4% |
| 382 | hemangiopericytoma | 4.4% |
| 383 | Lymphangioma | 4.4% |
| 384 | Mesenchymoma | 4.4% |
| 385 | Nevus | 4.4% |
| 386 | Teratoma | 4.4% |
| 387 | Hepatoblastoma | 4.4% |
| 388 | Mixed Tumor, Mullerian | 4.4% |
| 389 | Germinoma | 4.4% |
| 390 | Teratocarcinoma | 4.4% |
| 391 | Angiofibroma | 4.4% |
| 392 | Sarcoma | 4.4% |
| 393 | Epithelioma | 4.4% |
| 394 | Composite Lymphoma | 4.4% |
| 395 | Mycetoma | 4.3% |
| 396 | Brain Stem Neoplasms | 4.3% |
| 397 | Malignant Carcinoid Syndrome | 4.3% |
| 398 | Lupus Erythematosus, Systemic | 4.3% |
| 399 | Overlap syndrome | 4.3% |
| 400 | Myelitis, Transverse | 4.3% |
| 401 | Adenofibroma | 4.2% |
| 402 | Fibroadenoma | 4.2% |
| 403 | Malignant Fibrous Histiocytoma | 4.2% |
| 404 | Bladder Neoplasm | 4.2% |
| 405 | Kidney Neoplasm | 4.2% |
| 406 | Ureteral Neoplasms | 4.2% |
| 407 | Urethral Neoplasms | 4.2% |
| 408 | Glioblastoma | 4.2% |
| 409 | Neuroblastoma | 4.2% |
| 410 | Glioblastoma Multiforme | 4.2% |
| 411 | Hypopharyngeal Neoplasms | 4.1% |
| 412 | Pleural Effusion, Malignant | 4.1% |
| 413 | Hypopharyngeal Cancer | 4.1% |
| 414 | Choroid Plexus Papilloma | 4.1% |
| 415 | Parotid Neoplasms | 4% |
| 416 | Prostatic Neoplasms, Castration-Resistant | 4% |
| 417 | Bowen's Disease | 4% |
| 418 | Paraganglioma | 4% |
| 419 | Rhabdomyosarcoma | 4% |
| 420 | Giant Cell Tumor of Bone | 4% |
| 421 | Lymphoma | 4% |
| 422 | Nelson Syndrome | 4% |
| 423 | Basal Cell Nevus Syndrome | 4% |
| 424 | Renal Cell Carcinoma | 4% |
| 425 | Papillary Renal Cell Carcinoma | 4% |
| 426 | Larva Migrans | 4% |
| 427 | Leishmaniasis | 4% |
| 428 | Molluscum Contagiosum | 4% |
| 429 | Ganglioneuroblastoma | 4% |
| 430 | Corpus Luteum Cyst | 4% |
| 431 | Ovarian Cysts | 4% |
| 432 | Angioedema | 4% |
| 433 | Onchocerciasis | 4% |
| 434 | Chromoblastomycosis | 3.9% |
| 435 | Dermatophytosis | 3.9% |
| 436 | Sporotrichosis | 3.9% |
| 437 | Tinea | 3.9% |
| 438 | Tinea Versicolor | 3.9% |
| 439 | Trichophytosis | 3.9% |
| 440 | Hyalohyphomycosis | 3.9% |
| 441 | Acute Generalized Exanthematous Pustulosis | 3.9% |
| 442 | Dermatofibrosarcoma | 3.8% |
| 443 | Dermatofibrosarcoma Protuberans | 3.8% |
| 444 | Lichen Planus, Oral | 3.7% |
| 445 | Carcinoma, Endometrioid | 3.7% |
| 446 | Tonsillar Neoplasms | 3.6% |
| 447 | Cerebellar Neoplasms | 3.6% |
| 448 | Pheochromocytoma | 3.6% |
| 449 | Alveolar rhabdomyosarcoma | 3.6% |
| 450 | Hydatidiform Mole | 3.5% |
| 451 | Nasopharyngeal carcinoma | 3.5% |
| 452 | Endometrial Stromal Sarcoma | 3.5% |
| 453 | Cecal Neoplasms | 3.5% |
| 454 | Duodenal Neoplasms | 3.5% |
| 455 | Carcinoid Heart Disease | 3.5% |
| 456 | Choledochal Cyst | 3.4% |
| 457 | Warts | 3.4% |
| 458 | Neurofibrosarcoma | 3.3% |
| 459 | Pancreatic Pseudocyst | 3.3% |
| 460 | Plasmacytoma | 3.3% |
| 461 | Scleromyxedema | 3.3% |
| 462 | Candidiasis, Chronic Mucocutaneous | 3.3% |
| 463 | Cutaneous Candidiasis | 3.3% |
| 464 | Malignant histiocytosis | 3.3% |
| 465 | Lymphatic Metastasis | 3.3% |
| 466 | Neoplasms, Unknown Primary | 3.3% |
| 467 | Leukemic Infiltration | 3.3% |
| 468 | Histiocytic sarcoma | 3.3% |
| 469 | Neoplasm Micrometastasis | 3.3% |
| 470 | Adenocarcinoma | 3.3% |
| 471 | Carcinoma in Situ | 3.3% |
| 472 | Carcinoma, Transitional Cell | 3.3% |
| 473 | Phyllodes Tumor | 3.3% |
| 474 | Dysgerminoma | 3.3% |
| 475 | Erysipelas | 3.3% |
| 476 | Hemangioendothelioma | 3.3% |
| 477 | Lipoma | 3.3% |
| 478 | Myoma | 3.3% |
| 479 | Myxoma | 3.3% |
| 480 | Neuroma | 3.3% |
| 481 | Papilloma | 3.3% |
| 482 | Pseudomyxoma Peritonei | 3.3% |
| 483 | Seminoma | 3.3% |
| 484 | Serum Sickness | 3.3% |
| 485 | Staphylococcal Skin Infections | 3.3% |
| 486 | Variegate Porphyria | 3.3% |
| 487 | Acute intermittent porphyria | 3.3% |
| 488 | Porphyria Cutanea Tarda | 3.3% |
| 489 | Papillomatosis | 3.3% |
| 490 | Angiolipoma | 3.3% |
| 491 | Myelolipoma | 3.3% |
| 492 | Neoplasms, Bone Tissue | 3.3% |
| 493 | Neoplasms, Fibrous Tissue | 3.3% |
| 494 | Smooth Muscle Tumor | 3.3% |
| 495 | Adenomatosis, Pulmonary | 3.3% |
| 496 | Adenomatous Polyps | 3.3% |
| 497 | Carcinoma, Large Cell | 3.3% |
| 498 | Carcinoma, Small Cell | 3.3% |
| 499 | Desmoplastic Small Round Cell Tumor | 3.3% |
| 500 | Chondroma | 3.3% |
| 501 | Enchondroma | 3.3% |
| 502 | Giant Cell Arteritis | 3.3% |
| 503 | Temporal Arteritis | 3.3% |
| 504 | Erythrasma | 3.3% |
| 505 | CREST Syndrome | 3.2% |
| 506 | Lymphangioleiomyomatosis | 3.2% |
| 507 | Arthritis, Psoriatic | 3.2% |
| 508 | Denys-Drash Syndrome | 3.2% |
| 509 | Nasopharyngeal Neoplasms | 3.1% |
| 510 | Appendiceal Neoplasms | 3.1% |
| 511 | Colonic Neoplasms | 3.1% |
| 512 | Rectal Neoplasms | 3.1% |
| 513 | Colorectal Neoplasms | 3% |
| 514 | Leishmaniasis, Cutaneous | 2.9% |
| 515 | Eczema Herpeticum | 2.9% |
| 516 | Fusariosis | 2.9% |
| 517 | Cellulitis | 2.8% |
| 518 | Paranasal Sinus Neoplasms | 2.8% |
| 519 | Adenoid Cystic Carcinoma | 2.7% |
| 520 | fibroma | 2.7% |
| 521 | Fibromatosis | 2.7% |
| 522 | Osteoblastoma | 2.7% |
| 523 | Osteoma | 2.7% |
| 524 | Rhabdomyoma | 2.7% |
| 525 | Chondromatosis | 2.7% |
| 526 | Adenocarcinoma, Clear Cell | 2.7% |
| 527 | Cholangiocarcinoma | 2.7% |
| 528 | Cervical Intraepithelial Neoplasia | 2.7% |
| 529 | Hemangioblastoma | 2.7% |
| 530 | Lymphoma, Extranodal NK-T-Cell | 2.7% |
| 531 | Hodgkin Disease | 2.6% |
| 532 | Lymphoma, Non-Hodgkin | 2.6% |
| 533 | Polycystic Ovary Syndrome | 2.6% |
| 534 | Anus Neoplasms | 2.5% |
| 535 | Sigmoid Neoplasms | 2.5% |
| 536 | Mesenteric Panniculitis | 2.5% |
| 537 | Panniculitis, Peritoneal | 2.5% |
| 538 | Tietze's Syndrome | 2.5% |
| 539 | Orbital Cellulitis | 2.5% |
| 540 | Myxedema | 2.5% |
| 541 | Angioedemas, Hereditary | 2.5% |
| 542 | Blastomycosis | 2.5% |
| 543 | Epidermodysplasia Verruciformis | 2.5% |
| 544 | Herpes Labialis | 2.5% |
| 545 | Leukemia, Myelomonocytic, Chronic | 2.4% |
| 546 | Diabetic Foot | 2.4% |
| 547 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.4% |
| 548 | HIV-Associated Lipodystrophy Syndrome | 2.4% |
| 549 | Menkes Kinky Hair Syndrome | 2.4% |
| 550 | Fibromatosis, Aggressive | 2.4% |
| 551 | Fibromatosis, Abdominal | 2.4% |
| 552 | Klatskin Tumor | 2.4% |
| 553 | Maxillary Sinus Neoplasms | 2.4% |
| 554 | Staphylococcal Scalded Skin Syndrome | 2.4% |
| 555 | Hereditary Angioedema Type III | 2.4% |
| 556 | Hereditary Angioedema Types I and II | 2.4% |
| 557 | Rhinoscleroma | 2.2% |
| 558 | Primary amyloidosis | 2.2% |
| 559 | Condylomata Acuminata | 2.1% |
| 560 | Furunculosis | 2.1% |
| 561 | furuncle | 2.1% |
| 562 | Noonan Syndrome | 2.1% |
| 563 | Impetigo | 2.1% |
| 564 | Osteochondritis | 2% |
| 565 | Polymyalgia Rheumatica | 2% |
| 566 | Mastocytosis, Systemic | 2% |
| 567 | Leukemia, Myeloid, Chronic-Phase | 2% |
| 568 | Osteogenesis Imperfecta | 2% |
| 569 | Sturge-Weber Syndrome | 2% |
| 570 | carbuncle | 2% |
| 571 | Cell Transformation, Viral | 2% |
| 572 | Gastrointestinal Stromal Tumors | 2% |
| 573 | Hemangioma, Cavernous | 2% |
| 574 | Keloid | 2% |
| 575 | Leukemia, T-Cell | 1.9% |
| 576 | Leukemia, B-Cell | 1.9% |
| 577 | neurofibroma | 1.9% |
| 578 | Lymphoma, Follicular | 1.9% |
| 579 | T-Cell Lymphoma | 1.9% |
| 580 | Mantle cell lymphoma | 1.9% |
| 581 | Marfan Syndrome | 1.9% |
| 582 | Homocystinuria | 1.8% |
| 583 | Rheumatoid Arthritis | 1.7% |
| 584 | Juvenile arthritis | 1.7% |
| 585 | Waldenstrom Macroglobulinemia | 1.6% |
| 586 | Multiple Myeloma | 1.6% |
| 587 | Lupus Nephritis | 1.6% |
| 588 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 589 | Leukemia, Large Granular Lymphocytic | 1.6% |
| 590 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 591 | Lymphoma, T-Cell, Cutaneous | 1.6% |
| 592 | Lymphoma, AIDS-Related | 1.6% |
| 593 | Enteropathy-Associated T-Cell Lymphoma | 1.6% |
| 594 | Primary Effusion Lymphoma | 1.6% |
| 595 | Laryngomalacia | 1.5% |
| 596 | Zollinger-Ellison syndrome | 1.5% |
| 597 | Pectus carinatum | 1.4% |
| 598 | Mycosis Fungoides | 1.4% |
| 599 | Lymphomatoid Papulosis | 1.4% |
| 600 | Plasmablastic lymphoma | 1.4% |
| 601 | Rheumatoid Nodule | 1.3% |
| 602 | Burkitt Lymphoma | 1.2% |
| 603 | Felty Syndrome | 1.1% |
| 604 | Bronchomalacia | 1.1% |
| 605 | Tracheomalacia | 1.1% |
| 606 | Sezary Syndrome | 1% |
| 607 | Radicular Cyst | 1% |
| 608 | Rheumatoid Vasculitis | 0.9% |
| 609 | Mucopolysaccharidosis III | 0.9% |
| 610 | Sicca Syndrome | 0.8% |
| 611 | Sjogren's Syndrome | 0.8% |
| 612 | Lupus Vasculitis, Central Nervous System | 0.7% |
| 613 | Mucopolysaccharidosis II | 0.6% |